520 related articles for article (PubMed ID: 23042213)
1. Modulation of α7 nicotinic acetylcholine receptor and fibrillar amyloid-β interactions in Alzheimer's disease brain.
Ni R; Marutle A; Nordberg A
J Alzheimers Dis; 2013; 33(3):841-51. PubMed ID: 23042213
[TBL] [Abstract][Full Text] [Related]
2. Functional interactions of fibrillar and oligomeric amyloid-β with alpha7 nicotinic receptors in Alzheimer's disease.
Lilja AM; Porras O; Storelli E; Nordberg A; Marutle A
J Alzheimers Dis; 2011; 23(2):335-47. PubMed ID: 21116052
[TBL] [Abstract][Full Text] [Related]
3. Nicotinic receptor agonists and antagonists increase sAPPalpha secretion and decrease Abeta levels in vitro.
Mousavi M; Hellström-Lindahl E
Neurochem Int; 2009; 54(3-4):237-44. PubMed ID: 19111588
[TBL] [Abstract][Full Text] [Related]
4. ³H-deprenyl and ³H-PIB autoradiography show different laminar distributions of astroglia and fibrillar β-amyloid in Alzheimer brain.
Marutle A; Gillberg PG; Bergfors A; Yu W; Ni R; Nennesmo I; Voytenko L; Nordberg A
J Neuroinflammation; 2013 Jul; 10():90. PubMed ID: 23880036
[TBL] [Abstract][Full Text] [Related]
5. Presynaptic alpha7 and non-alpha7 nicotinic acetylcholine receptors modulate [3H]d-aspartate release from rat frontal cortex in vitro.
Rousseau SJ; Jones IW; Pullar IA; Wonnacott S
Neuropharmacology; 2005 Jul; 49(1):59-72. PubMed ID: 15992581
[TBL] [Abstract][Full Text] [Related]
6. Beta-amyloid peptide activates non-alpha7 nicotinic acetylcholine receptors in rat basal forebrain neurons.
Fu W; Jhamandas JH
J Neurophysiol; 2003 Nov; 90(5):3130-6. PubMed ID: 12890800
[TBL] [Abstract][Full Text] [Related]
7. Selective coactivation of α7- and α4β2-nicotinic acetylcholine receptors reverses beta-amyloid-induced synaptic dysfunction.
Roberts JP; Stokoe SA; Sathler MF; Nichols RA; Kim S
J Biol Chem; 2021; 296():100402. PubMed ID: 33571523
[TBL] [Abstract][Full Text] [Related]
8. Research update: Alpha7 nicotinic acetylcholine receptor mechanisms in Alzheimer's disease.
Parri HR; Hernandez CM; Dineley KT
Biochem Pharmacol; 2011 Oct; 82(8):931-42. PubMed ID: 21763291
[TBL] [Abstract][Full Text] [Related]
9. A novel nicotinic mechanism underlies β-amyloid-induced neurotoxicity.
Liu Q; Xie X; Emadi S; Sierks MR; Wu J
Neuropharmacology; 2015 Oct; 97():457-63. PubMed ID: 25959067
[TBL] [Abstract][Full Text] [Related]
10. S 24795 limits beta-amyloid-alpha7 nicotinic receptor interaction and reduces Alzheimer's disease-like pathologies.
Wang HY; Bakshi K; Shen C; Frankfurt M; Trocmé-Thibierge C; Morain P
Biol Psychiatry; 2010 Mar; 67(6):522-30. PubMed ID: 19932469
[TBL] [Abstract][Full Text] [Related]
11. Nicotinic Cholinergic Mechanisms in Alzheimer's Disease.
Shen J; Wu J
Int Rev Neurobiol; 2015; 124():275-92. PubMed ID: 26472533
[TBL] [Abstract][Full Text] [Related]
12. High selective expression of alpha7 nicotinic receptors on astrocytes in the brains of patients with sporadic Alzheimer's disease and patients carrying Swedish APP 670/671 mutation: a possible association with neuritic plaques.
Yu WF; Guan ZZ; Bogdanovic N; Nordberg A
Exp Neurol; 2005 Mar; 192(1):215-25. PubMed ID: 15698636
[TBL] [Abstract][Full Text] [Related]
13. JN403, in vitro characterization of a novel nicotinic acetylcholine receptor alpha7 selective agonist.
Feuerbach D; Nozulak J; Lingenhoehl K; McAllister K; Hoyer D
Neurosci Lett; 2007 Apr; 416(1):61-5. PubMed ID: 17314009
[TBL] [Abstract][Full Text] [Related]
14. The consequences of reducing expression of the alpha7 nicotinic receptor by RNA interference and of stimulating its activity with an alpha7 agonist in SH-SY5Y cells indicate that this receptor plays a neuroprotective role in connection with the pathogenesis of Alzheimer's disease.
Qi XL; Nordberg A; Xiu J; Guan ZZ
Neurochem Int; 2007; 51(6-7):377-83. PubMed ID: 17493709
[TBL] [Abstract][Full Text] [Related]
15. beta-Amyloid activates presynaptic alpha7 nicotinic acetylcholine receptors reconstituted into a model nerve cell system: involvement of lipid rafts.
Khan GM; Tong M; Jhun M; Arora K; Nichols RA
Eur J Neurosci; 2010 Mar; 31(5):788-96. PubMed ID: 20374280
[TBL] [Abstract][Full Text] [Related]
16. A novel nicotinic acetylcholine receptor subtype in basal forebrain cholinergic neurons with high sensitivity to amyloid peptides.
Liu Q; Huang Y; Xue F; Simard A; DeChon J; Li G; Zhang J; Lucero L; Wang M; Sierks M; Hu G; Chang Y; Lukas RJ; Wu J
J Neurosci; 2009 Jan; 29(4):918-29. PubMed ID: 19176801
[TBL] [Abstract][Full Text] [Related]
17. Restoring long-term potentiation impaired by amyloid-beta oligomers: comparison of an acetylcholinesterase inhibitior and selective neuronal nicotinic receptor agonists.
Kroker KS; Moreth J; Kussmaul L; Rast G; Rosenbrock H
Brain Res Bull; 2013 Jul; 96():28-38. PubMed ID: 23639920
[TBL] [Abstract][Full Text] [Related]
18. Amyloid tracers detect multiple binding sites in Alzheimer's disease brain tissue.
Ni R; Gillberg PG; Bergfors A; Marutle A; Nordberg A
Brain; 2013 Jul; 136(Pt 7):2217-27. PubMed ID: 23757761
[TBL] [Abstract][Full Text] [Related]
19. Memantine blocks alpha7* nicotinic acetylcholine receptors more potently than n-methyl-D-aspartate receptors in rat hippocampal neurons.
Aracava Y; Pereira EF; Maelicke A; Albuquerque EX
J Pharmacol Exp Ther; 2005 Mar; 312(3):1195-205. PubMed ID: 15522999
[TBL] [Abstract][Full Text] [Related]
20. Cortical alpha7 nicotinic acetylcholine receptor and beta-amyloid levels in early Alzheimer disease.
Ikonomovic MD; Wecker L; Abrahamson EE; Wuu J; Counts SE; Ginsberg SD; Mufson EJ; Dekosky ST
Arch Neurol; 2009 May; 66(5):646-51. PubMed ID: 19433665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
